Breaking News Instant updates and real-time market news.

2020-08-10 07:11:00 VYGR Voyager Therapeutics $11.24 / +0.24 (+2.18%) 07:11 08/10/20 08/10 07:11 08/10/20 07:11	Voyager Therapeutics announces anticipated upcoming milestones VY-AADC for Parkinson's Disease: Report 3-year results from PD-1101 trial September 2020; Report 2-year results from PD-1102 trial -September 2020; Resume patient screening and enrollment in RESTORE-1 Phase 2 clinical trial 2H 2020 Initiate RESTORE-2 Phase 3 registrational clinical trial 1H 2020. VY-HTT01 for Huntington's Disease: IND application and Phase 1 trial initiation update post-FDA clearance; Present IND-enabling preclinical results at a scientific congress 1H 2021. Early Pipeline and Platform: Provide progress updates on earlier-stage research programs, including novel capsid discovery efforts	11 Aug 09 Sep
VYGR Voyager Therapeutics $11.24 / +0.24 (+2.18%) 08/05/20 Benchmark Voyager 'break up' with AbbVie has no impact on valuation, says Benchmark 08/04/20 H.C. Wainwright Voyager Therapeutics price target lowered to $14 from $18 at H.C. Wainwright 03/30/20 Nomura Voyager Therapeutics price target lowered to $16 from $37 at Nomura Instinet 03/19/20 Fly Intel: Top five analyst initiations

2020-08-10 07:11:00

VYGR

Voyager Therapeutics

$11.24 / +0.24 (+2.18%)

07:11

08/10/20

08/10

07:11

08/10/20

07:11

Voyager Therapeutics announces anticipated upcoming milestones

VY-AADC for Parkinson's Disease: Report 3-year results from PD-1101 trial September 2020; Report 2-year results from PD-1102 trial -September 2020; Resume patient screening and enrollment in RESTORE-1 Phase 2 clinical trial 2H 2020 Initiate RESTORE-2 Phase 3 registrational clinical trial 1H 2020. VY-HTT01 for Huntington's Disease: IND application and Phase 1 trial initiation update post-FDA clearance; Present IND-enabling preclinical results at a scientific congress 1H 2021. Early Pipeline and Platform: Provide progress updates on earlier-stage research programs, including novel capsid discovery efforts

11
Aug
09
Sep

VYGR Voyager Therapeutics

$11.24 / +0.24 (+2.18%)

08/05/20 Benchmark: Voyager 'break up' with AbbVie has no impact on valuation, says Benchmark

08/04/20 H.C. Wainwright: Voyager Therapeutics price target lowered to $14 from $18 at H.C. Wainwright

03/30/20 Nomura: Voyager Therapeutics price target lowered to $16 from $37 at Nomura Instinet

03/19/20: Fly Intel: Top five analyst initiations

TODAY'S FREE FLY STORIES

Initiation	Daqo New Energy initiated with a Sell at GLJ Research » 11:39 04/13/21 04/13 11:39 04/13/21 11:39 DQ Daqo New Energy $66.50 / -0.54 (-0.81%) GLJ Research analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/16/21 Daqo New Energy enters three-year polysilicon supply agreement with Gaojing 03/09/21 Daqo New Energy rises 22.7% 03/09/21 Daqo New Energy rises 16.2% 03/09/21 Daqo New Energy rises 14.1% DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/10/21 Roth Capital Daqo New Energy price target lowered to $97 from $115 at Roth Capital 03/02/21 Roth Capital Daqo New Energy price target raised to $115 from $105 at Roth Capital 02/08/21 Roth Capital Bill could be 'meaningful positive' for solar stocks, says Roth Capital 01/26/21 Roth Capital Daqo New Energy price target raised to $100 from $40 at Roth Capital DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/09/21 Daqo New Energy reports Q4 EPS $1.07, one estimate $1.15 DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 01/08/21 JinkoSolar, Daqo named in report on companies tied to forced labor use, NYT says DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 03/09/21 Fly Intel: Pre-market Movers 02/13/21 Charged: Tesla discloses $1.5B bitcoin investment 01/09/21 Charged: Apple self-driving EV said to be years away 12/26/20 Charged: Apple's potential EV entry seen as 'Tesla bear case' 04/22/21 Alternative Energy DQ Daqo New Energy $66.50 / -0.54 (-0.81%) 02/25/21 Daqo New Energy call volume above normal and directionally bullish 01/11/21 Daqo New Energy put volume heavy and directionally bearish
Hot Stocks	MoneyGram announces partnership with Sigue Corporation » 11:34 04/13/21 04/13 11:34 04/13/21 11:34 MGI MoneyGram $6.46 / -0.01 (-0.15%) MoneyGram International… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options MGI MoneyGram $6.46 / -0.01 (-0.15%) 04/06/21 MoneyGram appoints Hilary Jackson as COO 03/24/21 MoneyGram announces launch of 'MoneyGram as a Service' business 03/18/21 MoneyGram to join Pay+ mobile wallet, expand in Middle East 03/11/21 MoneyGram's digital business reports 118% y-o-y transaction growth in February MGI MoneyGram $6.46 / -0.01 (-0.15%) 02/25/21 Barclays MoneyGram price target raised to $6 from $4.50 at Barclays 01/19/21 DA Davidson DA Davidson doesn't see Walmart adding Western Union to hurt Euronet materially 01/11/21 Northland MoneyGram upgraded to Outperform from Market Perform at Northland 08/03/20 Evercore ISI MoneyGram upgraded to In Line from Underperform at Evercore ISI MGI MoneyGram $6.46 / -0.01 (-0.15%) 02/22/21 MoneyGram sees Q1 revenue approximately $300M, consensus $298.53M 02/22/21 MoneyGram reports Q4 adjusted EPS 12c, consensus 8c 01/25/21 Fly Intel: What to watch in credit card space earnings reports 10/30/20 MoneyGram sees Q4 revenue growth of 1%, consensus $308.02M MGI MoneyGram $6.46 / -0.01 (-0.15%) 12/21/20 MoneyGram backs stronger due diligence rule, WSJ reports MGI MoneyGram $6.46 / -0.01 (-0.15%) 03/12/21 The Intersection: Crypto and Wall Street This Week 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers 05/05/21 MoneyGram International Inc MGI MoneyGram $6.46 / -0.01 (-0.15%) 12/16/20 MoneyGram call volume above normal and directionally bullish 12/03/20 MoneyGram call volume above normal and directionally bullish 11/20/20 MoneyGram call volume above normal and directionally bullish 11/16/20 MoneyGram call volume above normal and directionally bullish
Recommendations	Novocure price target raised to $215 from $135 at Wells Fargo » 11:34 04/13/21 04/13 11:34 04/13/21 11:34 NVCR Novocure $183.50 / +51.89 (+39.43%) Wells Fargo analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events NVCR Novocure $183.50 / +51.89 (+39.43%) 07:48 Today Zai Lab partner Novocure updates phase 3 Lunar trial in tumor fields in NSCLC 07:40 Today Novocure: DMC recommends continuation of LUNAR trial 12/14/20 Novocure announces BAG to add Optune combination to MiGeL 12/10/20 Novocure enrolls 1st patient in global phase 3 TRIDENT trial NVCR Novocure $183.50 / +51.89 (+39.43%) 10:48 Today Guggenheim Zai Lab price target raised to $250 from $165 at Guggenheim 09:26 Today Piper Sandler DMC review 'clear positive' for Novocure, says Piper Sandler 03/01/21 Mizuho Novocure price target raised to $175 from $150 at Mizuho 02/25/21 Piper Sandler 'Overreaction to downside' in Novocure a buying opportunity, says Piper Sandler NVCR Novocure $183.50 / +51.89 (+39.43%) 02/25/21 Novocure reports Q4 EPS 4c, consensus 12c 01/11/21 Novocure sees FY20 revenue $494.4M, consensus $482.29M 01/11/21 Novocure sees Q4 revenue $144M, consensus $133.26M 10/29/20 Novocure reports Q3 EPS 9c, consensus 3c NVCR Novocure $183.50 / +51.89 (+39.43%) 08:58 Today Fly Intel: Pre-market Movers 04/29/21 Novocure - NVCR
Periodicals	GM shortens expected downtime at Tennessee plant, CNBC reports » 11:28 04/13/21 04/13 11:28 04/13/21 11:28 GM General Motors $58.37 / -1.295 (-2.17%) General Motors is… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options GM General Motors $58.37 / -1.295 (-2.17%) 04/12/21 General Motors launches Maps+ in-vehicle navigation solution 04/06/21 GM says Chevrolet will introduce Silverado electric pickup truck 04/05/21 GM to reveal plans for additional EV production at Factory ZERO plant 04/01/21 GM targets recovering lost production where possible in second half GM General Motors $58.37 / -1.295 (-2.17%) 04/05/21 Fly Intel: Top five analyst initiations 04/05/21 Wells Fargo General Motors initiated with an Overweight at Wells Fargo 03/29/21 Jefferies General Motors price target raised to $62 from $50 at Jefferies 03/24/21 Morgan Stanley American Axle downgraded to Underweight on ICE phase out risk at Morgan Stanley GM General Motors $58.37 / -1.295 (-2.17%) 02/10/21 General Motors sees FY21 EBIT-adjusted of $1.5B-$2B 02/10/21 General Motors reports Q4 International EBIT-adjusted of $0.3B 02/10/21 General Motors sees FY21 adjusted EPS $4.50-$5.25, consensus $5.89 02/10/21 General Motors reports Q4 GM North America EBIT-adjusted of $2.6B GM General Motors $58.37 / -1.295 (-2.17%) 04/12/21 Chip shortage meeting not seen producing substantive outcomes, Bloomberg says 04/12/21 General Motors' Cruise to expand self-driving vehicles to Dubai, CNBC reports 04/09/21 GM to cut overtime production at two U.S. truck plants this weekend, CNBC says 04/08/21 GM to pause output at several North American plants amid chip shortage, WSJ says GM General Motors $58.37 / -1.295 (-2.17%) 04/12/21 Charged: White House proposal calling for $100B in new EV consumer rebates 04/06/21 Fly Intel: Wall Street's top stories for Tuesday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/05/21 Charged: Wedbush says buy Tesla after 'paradigm changer' deliveries GM General Motors $58.37 / -1.295 (-2.17%) 04/07/21 Notable open interest changes for April 7th 03/24/21 General Motors call volume above normal and directionally bullish 03/03/21 Notable open interest changes for March 3rd 03/02/21 General Motors call volume above normal and directionally bullish
Options	iQiyi call volume above normal and directionally bullish » 11:25 04/13/21 04/13 11:25 04/13/21 11:25 IQ iQIYI $16.69 / +0.515 (+3.18%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Options IQ iQIYI $16.69 / +0.515 (+3.18%) 03/31/21 Moonbug Entertainment brings CoComelon to China through iQIYI partnership 03/15/21 iQIYI, Clover Films announce collaboration for four upcoming film productions 02/10/21 iQIYI Launches Imax Enhanced in China 02/08/21 Aurora Mobile enters partnership agreement with iQIYI IQ iQIYI $16.69 / +0.515 (+3.18%) 02/22/21 KeyBanc iQIYI upgraded to Overweight from Sector Weight at KeyBanc 02/18/21 Fly Intel: Top five analyst downgrades 02/18/21 JPMorgan iQIYI downgraded to Underweight from Neutral at JPMorgan 01/19/21 UBS iQIYI downgraded to Neutral from Buy at UBS IQ iQIYI $16.69 / +0.515 (+3.18%) 02/17/21 iQIYI sees Q1 revenue $1.08B-$1.15B, consensus $1.13B 02/17/21 iQIYI reports Q4 EPS (32c), consensus (38c) 11/16/20 iQIYI sees Q4 revenue $1.07B-$1.14B, consensus $1.13B 11/16/20 iQIYI reports Q3 EPS (24c), consensus (40c) 17 Dec IQ iQIYI $16.69 / +0.515 (+3.18%) 03/29/21 Former Tiger Asia manager triggered $30B in stock sales, WSJ reports 12/02/20 House approves bill restricting Chinese firms on U.S exchanges, Bloomberg says 11/27/20 Alibaba, Tencent put talks to buy control of iQIYI on hold, Reuters reports 10/13/20 Chinese online video platforms drop Apple iPhone event, Bloomberg's Yuan reports IQ iQIYI $16.69 / +0.515 (+3.18%) 03/29/21 Analysts upgrade ViacomCBS, GSX Techedu as selloff in shares continues 12/16/20 Fly Intel: Pre-market Movers 12/15/20 Fly Intel: After-Hours Movers 11/16/20 Fly Intel: After-Hours Movers IQ iQIYI $16.69 / +0.515 (+3.18%) 04/07/21 Notable open interest changes for April 7th 04/06/21 iQiyi call volume above normal and directionally bullish 04/06/21 Unusually active option classes on open April 6th 03/25/21 iQiyi put volume heavy and directionally bearish

Conference/Events	Cowen Washington strategist to hold analyst/industry conference call » 11:25 04/13/21 04/13 11:25 04/13/21 11:25 Washington Strategist… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Periodicals	KKR planning to outbid CVC for Toshiba with offer in excess of $20B, FT reports » 11:23 04/13/21 04/13 11:23 04/13/21 11:23 TOSYY Toshiba $20.85 / +0.03 (+0.14%) , KKR KKR $52.09 / +0.08 (+0.15%) KKR (KKR) is planning to… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 04/09/21 Toshiba chairperson Osamu Nagayama comments on CVC Capital acquisition proposal 04/06/21 Toshiba confirms acquisition proposal from CVC Capital 03/02/21 Farallon Capital urges Toshiba shareholders to support Farallon EGM proposal KKR KKR $52.09 / +0.08 (+0.15%) 04/08/21 KKR to lead purchase of $500M of convertible preferred stock in Box 04/08/21 Box reaffirms vision to deliver Content Cloud, drive profitable growth 04/08/21 Box announces partnership with KKR, including $500M KKR-led investment 04/08/21 Box announces partnership with KKR, including $500M KKR-led investment TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 03/19/21 SMBC Nikko Toshiba upgraded to Outperform from Neutral at SMBC Nikko 02/19/21 Citi Toshiba resumed with a Neutral at Citi 04/22/20 UBS Toshiba downgraded to Neutral from Buy at UBS KKR KKR $52.09 / +0.08 (+0.15%) 04/09/21 DA Davidson Box price target lowered to $22 from $25 at DA Davidson 04/09/21 William Blair KKR investment 'strong vote of confidence' in Box, says William Blair 04/09/21 William Blair KKR investment 'strong vote of confidence' in Box, says William Blair 04/07/21 Seaport Global Seaport downgrades Sempra Energy to Neutral after 'good, not great' SIP deal KKR KKR KKR $52.09 / +0.08 (+0.15%) 02/08/21 KKR reports Q4 EPS 49c, consensus 40c 02/08/21 Notable companies reporting after market close 10/30/20 KKR reports Q3 EPS 48c, consensus 40c 11 Nov TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 04/06/21 CVC to propose taking Toshiba private at 30% premium, Nikkei says 12/29/20 Toshiba holds emergency board meeting amid investor demands, FT reports 12/18/20 Toshiba shareholder escalates dispute with management, FT reports 12/14/20 Toshiba, Fuji Electric to invest $1.9B in EV power chips, Nikkei reports KKR KKR $52.09 / +0.08 (+0.15%) 03/23/21 Thoma Bravo to acquire Calabrio from KKR, no terms, Reuters reports 03/17/21 Fly Leasing receives six bids for aircraft leasing portfolio, AFJ reports 03/11/21 KKR targets $12B for flagship global infrastructure fund, Reuters reports 02/19/21 Apple demands Steam sales data from Valve, PCGamer reports TOSYY KKR TOSYY Toshiba $20.85 / +0.03 (+0.14%) 04/06/21 Fly Intel: Wall Street's top stories for Tuesday KKR KKR $52.09 / +0.08 (+0.15%) 04/08/21 Fly Intel: Wall Street's top stories for Thursday 04/08/21 Fly Intel: Wall Street's top stories at midday 03/09/21 Game On: Microsoft completes Bethesda deal, promises exclusive games 01/12/21 Game On: Roblox files for direct listing as GameStop adds new directors 08:30 Today KKR & Co. Inc.
Recommendations	Stelco Holdings price target raised to C$34 from C$29 at RBC Capital » 11:20 04/13/21 04/13 11:20 04/13/21 11:20 STZHF Stelco Holdings $23.05 / -0.23 (-0.99%) RBC Capital analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research Events STZHF Stelco Holdings $23.05 / -0.23 (-0.99%) 03/31/21 Scotiabank Stelco Holdings price target raised to C$32 from C$30 at Scotiabank 02/24/21 RBC Capital Stelco Holdings upgraded to Outperform from Sector Perform at RBC Capital 02/22/21 Exane BNP Paribas Stelco Holdings upgraded to Outperform from Neutral at Exane BNP Paribas 02/03/21 Credit Suisse Stelco Holdings upgraded to Outperform from Neutral at Credit Suisse 00:00 Today Scrap, Direct Reduced Iron & Mini-Mills 2021
General news	Treasury announced an $80 B set of 4- and 8-week bill auctions for Thursday » 11:20 04/13/21 04/13 11:20 04/13/21 11:20 $ECON Economic Data / + Treasury announced an $80… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><<
Recommendations	Ascot Resources price target lowered to C$1.85 from C$2 at Desjardins » 11:19 04/13/21 04/13 11:19 04/13/21 11:19 AOTVF Ascot Resources / + Desjardins analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research AOTVF Ascot Resources / + 03/18/21 Ascot Resources provides update on permitting, engineering of PGP 11/19/20 Ascot Resources announces high-grade gold intercepts at the Day Zone 10/15/20 Ascot Resources places order for SAG, ball mills AOTVF Ascot Resources / + 12/11/20 Raymond James Ascot Resources price target raised to C$2 from C$1.75 at Raymond James 09/25/20 Raymond James Ascot Resources initiated with a Strong Buy at Raymond James 04/29/20 Roth Capital Roth Capital bullish on Ascot Resources, initiates with a Buy 04/29/20 Roth Capital Ascot Resources initiated with a Buy at Roth Capital

Recommendations	Rigel results in severe COVID-19 trial 'pretty dramatic,' says Piper Sandler » 11:19 04/13/21 04/13 11:19 04/13/21 11:19 RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) After Rigel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 07:07 Today Rigel announces results from Phase 2 clinical trial of fostamatinib 04/07/21 Rigel Pharmaceuticals closes R552 licensing agreement with Eli Lilly 03/11/21 Rigel Pharma completes patient enrollment for Phase 2 trial of fostamatinib 02/18/21 Eli Lilly, Rigel Pharmaceuticals enter exclusive license agreement for R552 RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 11/09/20 Fly Intel: Top five analyst downgrades 11/09/20 JPMorgan Rigel Pharmaceuticals downgraded to Neutral from Overweight at JPMorgan RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 03/02/21 Rigel Pharmaceuticals reports Q4 EPS (11c), consensus (11c) 01/11/21 Rigel Pharmaceuticals sees Q4 revenue approximately $18.4M, consensus $17.81M 11/05/20 Rigel Pharmaceuticals reports Q3 EPS (8c), consensus (12c) RIGL Rigel Pharmaceuticals $3.50 / +0.405 (+13.09%) 01/15/21 Rigel looks to choke 'storm' that causes Covid patients to die, SFBT says 08:00 Today Rigel Pharmaceuticals - RIGL 05/18/21 Rigel Pharmaceuticals Inc.
Conference/Events	Immunocore participates in a conference call with JPMorgan » 11:19 04/13/21 04/13 11:19 04/13/21 11:19 IMCR Immunocore $34.25 / +2.03 (+6.30%) SMid Cap Biotech Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events IMCR Immunocore $34.25 / +2.03 (+6.30%) 03/25/21 Immunocore expects cash to fund requirement through at least the end of 2022 02/19/21 Immunocore's tebentafusp granted Breakthrough Therapy Designation IMCR Immunocore $34.25 / +2.03 (+6.30%) 03/02/21 Jefferies Immunocore initiated with a Buy at Jefferies 03/02/21 JPMorgan Immunocore initiated with an Overweight at JPMorgan 03/02/21 Goldman Sachs Immunocore initiated with a Neutral at Goldman Sachs IMCR Immunocore $34.25 / +2.03 (+6.30%) 03/25/21 Immunocore reports 2020 EPS (GBP2.79) vs. (GBP4.66) last year 05 Feb IMCR Immunocore $34.25 / +2.03 (+6.30%) 02/07/21 Opening Day: Sana raises largest-ever IPO for preclinical biotech 07:30 Today Immunocore - IMCR 04/14/21 Immunocore - IMCR
Technical Analysis	NASDAQ market internals summary » 11:17 04/13/21 04/13 11:17 04/13/21 11:17 $NSD NASDAQ Market Internals / + Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals / + 10:17 Today NASDAQ market internals summary 04/12/21 NASDAQ market internals summary 04/12/21 NASDAQ market internals summary 04/12/21 NASDAQ market internals summary
Conference/Events	Akero Therapeutics participates in a conference call with JPMorgan » 11:16 04/13/21 04/13 11:16 04/13/21 11:16 AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) SMid Cap Biotech Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly Events AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/23/21 Akero says1st patient randomized for dosing in EFX study in F2/F3 NASH patients 03/22/21 Akero Therapeutics histological improvements in cirrhotic NASH post cohort C 11/13/20 Akero announces presentation of additional BALANCED study data analysis 10/16/20 Akero Therapeutics receives EMA PRIME designation for efruxifermin in NASH AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/23/21 H.C. Wainwright Akero Therapeutics price target raised to $68 from $61 at H.C. Wainwright 03/23/21 Chardan Akero NASH data 'very exciting outcome,' says Chardan 03/17/21 Chardan Akero Therapeutics price target raised to $81 from $79 at Chardan 02/26/21 Guggenheim Akero Therapeutics initiated with a Buy at Guggenheim AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/16/21 Akero Therapeutics reports Q4 EPS (86c), consensus (59c) 11/12/20 Akero Therapeutics reports Q3 EPS (63c), consensus (65c) 08 Jul AKRO Akero Therapeutics $26.88 / -0.29 (-1.07%) 03/16/21 Fly Intel: Pre-market Movers 13:00 Today Akero Therapeutics - AKRO
Technical Analysis	NYSE market internals summary » 11:16 04/13/21 04/13 11:16 04/13/21 11:16 $NYE NYSE Market Internals / + Volume is average for… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals / + 10:16 Today NYSE market internals summary 04/12/21 NYSE market internals summary 04/12/21 NYSE market internals summary 04/12/21 NYSE market internals summary

Recommendations	Western Forest price target raised to C$2.50 from C$1.90 at CIBC » 11:15 04/13/21 04/13 11:15 04/13/21 11:15 WFSTF Western Forest $1.59 / -0.0029 (-0.18%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research WFSTF Western Forest $1.59 / -0.0029 (-0.18%) 03/03/21 Scotiabank Western Forest price target raised to C$2.25 from C$2 at Scotiabank 02/22/21 RBC Capital Western Forest price target raised to C$2 from C$1.50 at RBC Capital 02/22/21 TD Securities Western Forest price target raised to C$2 from C$1.75 at TD Securities 02/19/21 Scotiabank Western Forest price target raised to C$2 from C$1.50 at Scotiabank
Recommendations	West Fraser Timber price target raised to C$135 from C$120 at CIBC » 11:15 04/13/21 04/13 11:15 04/13/21 11:15 WFG West Fraser Timber $82.77 / +0.95 (+1.16%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research WFG West Fraser Timber $82.77 / +0.95 (+1.16%) 04/07/21 Scotiabank West Fraser Timber price target raised to C$120 from C$106 at Scotiabank 03/26/21 TD Securities West Fraser Timber upgraded to Action List Buy from Buy at TD Securities 03/03/21 Scotiabank West Fraser Timber price target raised to C$106 from C$103 at Scotiabank 02/16/21 TD Securities West Fraser Timber price target raised to $91 from $86 at TD Securities
Options	Charles Schwab put volume heavy and directionally bearish » 11:15 04/13/21 04/13 11:15 04/13/21 11:15 SCHW Charles Schwab $67.09 / -0.63 (-0.93%) Bearish flow noted in… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 01/29/21 Charles Schwab says trading not restricted in GameStop, others 12/21/20 Charles Schwab unit fined GBP8.96M by U.K.'s Financial Conduct Authority 11/13/20 Charles Schwab reports October core new assets of $25.6B 10/29/20 Charles Schwab CFO says near-term accretion math 'better' for TD Ameritrade deal SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 04/09/21 Fly Intel: Top five analyst upgrades 04/09/21 Jefferies Charles Schwab price target raised to $76 from $70 at Jefferies 04/09/21 JPMorgan Charles Schwab price target raised to $81 from $79 at JPMorgan 04/09/21 Deutsche Bank Charles Schwab price target raised to $79 from $77 at Deutsche Bank SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 01/19/21 Charles Schwab reports Q4 adjusted EPS 74c, consensus 71c 10/15/20 Charles Schwab reports Q3 adj. EPS 51c, consensus 46c 10/14/20 Notable companies reporting before tomorrow's open 10/14/20 Notable companies reporting before tomorrow's open SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 03/04/21 Charles Schwab considering launching crypto brokerage, The Block reports 02/10/21 Charles Schwab cuts 200 workers amid TD Ameritrade integration, Bloomberg says 11/17/20 Trading platform Robinhood may go public next year, Bloomberg reports 10/15/20 Robinhood says almost 2,000 brokerage accounts hacked, Bloomberg reports SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 03/05/21 The Intersection: Crypto and Wall Street This Week 03/04/21 Fly Intel: Wall Street's top stories for Thursday 02/01/21 Square Cash App seen emerging as biggest winner from 'Robinhood drama' 10/15/20 Fly Intel: Pre-market Movers 05/13/21 Charles Schwab Corp. SCHW Charles Schwab $67.09 / -0.63 (-0.93%) 03/29/21 Charles Schwab put volume heavy and directionally bearish 02/10/21 Charles Schwab put volume heavy and directionally bearish 02/03/21 Charles Schwab put volume heavy and directionally bearish 01/28/21 Charles Schwab put volume heavy and directionally bearish
Recommendations	Toromont Industries price target raised to C$100 from C$95 at CIBC » 11:14 04/13/21 04/13 11:14 04/13/21 11:14 TMTNF Toromont Industries $77.45 / -0.33 (-0.42%) CIBC analyst Jacob Bout… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research TMTNF Toromont Industries $77.45 / -0.33 (-0.42%) 04/06/21 Scotiabank Toromont Industries price target raised to C$115 from C$100 at Scotiabank 04/06/21 Scotiabank Scotiabank upgrades Toromont to Outperform, says premium valuation warranted 04/05/21 Scotiabank Toromont Industries upgraded to Outperform from Sector Perform at Scotiabank 02/16/21 TD Securities Toromont Industries price target raised to C$98 from C$95 at TD Securities
On The Fly	Johnson & Johnson under pressure as FDA calls for pause on COVID vaccine » 11:12 04/13/21 04/13 11:12 04/13/21 11:12 JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) , MRNA Moderna $150.11 / +10.82 (+7.77%) , PFE Pfizer $37.14 / +0.16 (+0.43%) Shares of Johnson &… Open Full Text ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:25 Today Johnson & Johnson to 'proactively delay' rollout of vaccine in Europe 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 07:15 Today J&J drops 3% to $156.50 after CDC, FDA recommend pause in vaccine use MRNA Moderna $150.11 / +10.82 (+7.77%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 09:28 Today Moderna says available mRNA-1273 data doesn't suggest association with CVST 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 04/07/21 Moderna says NEJM study shows COVID antibody persistence out to 6 months PFE Pfizer $37.14 / +0.16 (+0.43%) 09:47 Today White House says J&J pause will not significantly impact vaccination plan 07:53 Today Moderna up 7% to $149.10 after CDC, FDA recommend pause in J&J vaccine use 04/12/21 AgroFresh Solutions appoints Clinton Lewis Jr. as CEO 04/12/21 Myovant Sciences, Pfizer: First patient dosed in Phase 3 SERENE study JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 09:34 Today Goldman Sachs J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause MRNA Moderna $150.11 / +10.82 (+7.77%) 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 08:15 Today Piper Sandler Piper reiterates $208 target on Moderna after J&J Covid vaccine pause 04/07/21 Jefferies Catalent pact with Moderna removes potential overhang, says Jefferies 03/15/21 Piper Sandler Piper Sandler bullish on Moderna as first subject vaccinated in '1283 study PFE Pfizer $37.14 / +0.16 (+0.43%) 09:33 Today Morgan Stanley Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers 09:21 Today JPMorgan Vaccine pause 'incremental negative' for J&J, says JPMorgan 04/09/21 Pfizer to host conference call 04/06/21 RBC Capital Pfizer transferred with a Sector Perform at RBC Capital JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 01/26/21 Johnson & Johnson sees FY21 adjusted operational EPS $9.25-$9.45 01/26/21 Johnson & Johnson reports Q4 adjusted EPS $1.86, consensus $1.82 01/25/21 Notable companies reporting before tomorrow's open 01/25/21 Notable companies reporting before tomorrow's open MRNA Moderna $150.11 / +10.82 (+7.77%) 02/25/21 Moderna reports Q4 EPS (69c), consensus (35c) 02/24/21 Notable companies reporting before tomorrow's open 02/24/21 Notable companies reporting before tomorrow's open 10/29/20 Moderna reports Q3 EPS (59c), consensus (43c) PFE Pfizer $37.14 / +0.16 (+0.43%) 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer raises FY21 adjusted EPS view to $3.10-$3.20, consensus $3.19 02/02/21 Pfizer reports Q4 adjusted EPS 42c, consensus 48c 02/01/21 Notable companies reporting before tomorrow's open 19 May JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 09:48 Today CVS Health tells Bloomberg pausing administration of J&J COVID vaccine 07:00 Today U.S. to call for pause on J&J vaccine after blood clotting cases, NYT reports 04/09/21 J&J in talks for trial in India of COVID-19 vaccine, Business Standard says MRNA Moderna $150.11 / +10.82 (+7.77%) 04/06/21 U.K. to initiate Moderna vaccine rollout Wednesday, Bloomberg says 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says 04/06/21 Catalent to nearly double Moderna vaccine output at Indiana plant, WSJ reports 03/26/21 White House weighs lifting IP protections for COVID-19 vaccines, CNBC says PFE Pfizer $37.14 / +0.16 (+0.43%) 09:48 Today NY replacing Tuesday's J&J vaccine appointments with Pfizer, Axios reports 04/12/21 Study shows Covid variant may evade protection from Pfizer vaccine, Reuters says 04/09/21 EU seeks contract for 1.8B COVID-19 doses with Pfizer, BioNTech, Reuters reports 04/06/21 Biden to say all U.S. adults should be vaccine-eligible by April 19, WSJ says JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 08:58 Today Fly Intel: Pre-market Movers 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 04/05/21 Fly Intel: Wall Street's top stories for Monday MRNA Moderna $150.11 / +10.82 (+7.77%) 08:58 Today Fly Intel: Pre-market Movers 04/06/21 Fly Intel: Wall Street's top stories for Tuesday 04/06/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Wall Street's top stories for Monday PFE Pfizer $37.14 / +0.16 (+0.43%) 04/10/21 Opening Day: Phone maker UTime soars in public debut 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/05/21 Fly Intel: Wall Street's top stories for Monday 04/01/21 Fly Intel: Wall Street's top stories for Thursday 04/20/21 Johnson & Johnson - JNJ 05/04/21 Pfizer - PFE 05/07/21 Moderna - MRNA 12/29/21 PDUFA Date for Lorbrena (Lorlatinib) April 2021 04/14/21 Moderna 04/22/21 Pfizer Inc 04/22/21 Johnson & Johnson 04/28/21 Moderna, Inc. JNJ MRNA PFE JNJ Johnson & Johnson $157.42 / -4.165 (-2.58%) 09:40 Today Unusually active option classes on open April 13th 04/01/21 Unusually active option classes on open April 1st 03/01/21 Unusually active option classes on open March 1st 01/26/21 Early notable gainers among liquid option names on January 26th MRNA Moderna $150.11 / +10.82 (+7.77%) 10:25 Today Moderna call volume above normal and directionally bullish 03/17/21 Moderna call volume above normal and directionally bullish 03/01/21 Moderna call volume above normal and directionally bullish 02/01/21 Moderna call volume above normal and directionally bullish PFE Pfizer $37.14 / +0.16 (+0.43%) 04/12/21 Unusually active option classes on open April 12th 04/09/21 Pfizer call volume above normal and directionally bullish 04/09/21 Early notable gainers among liquid option names on April 9th 03/15/21 Pfizer call volume above normal and directionally bullish

Conference/Events	JPMorgan biotech/pharma analysts hold an analyst/industry conference call » 11:10 04/13/21 04/13 11:10 04/13/21 11:10 Biotechnology Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Recommendations	Stella-Jones price target raised to C$60 from C$57 at CIBC » 11:10 04/13/21 04/13 11:10 04/13/21 11:10 STLJF Stella-Jones $41.00 / + (+0.00%) CIBC analyst Hamir Patel… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research STLJF Stella-Jones $41.00 / + (+0.00%) 03/12/21 Desjardins Stella-Jones price target raised to C$61 from C$55 at Desjardins 03/11/21 CIBC Stella-Jones price target raised to C$57 from C$54 at CIBC 03/11/21 RBC Capital Stella-Jones price target raised to C$55 from C$53 at RBC Capital 03/11/21 TD Securities Stella-Jones price target raised to C$59 from C$56 at TD Securities
Recommendations	Stantec price target raised to C$62 from C$56 at CIBC » 11:09 04/13/21 04/13 11:09 04/13/21 11:09 STN Stantec $45.10 / -0.62 (-1.36%) CIBC analyst Jacob Bout… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events STN Stantec $45.10 / -0.62 (-1.36%) 04/08/21 Stantec signs LOI to acquire Engenium consultancy in Australia 03/26/21 Stantec, BlueSky Resources partner on tracking data for air pollutants 02/23/21 Stantec and Hensel Phelps selected by WMATA for $225M project 02/16/21 Stantec signs agreement to acquire GTA Consultants STN Stantec $45.10 / -0.62 (-1.36%) 03/01/21 Desjardins Stantec price target raised to C$57 from C$56 at Desjardins 02/26/21 Canaccord Stantec price target raised to C$55 from C$50 at Canaccord 02/26/21 BMO Capital Stantec price target raised to C$56 from C$50 at BMO Capital 02/26/21 RBC Capital Stantec price target raised to C$48 from C$45 at RBC Capital STN Stantec $45.10 / -0.62 (-1.36%) 11/04/20 Stantec sees FY20 revenues slightly below FY19 level 11/04/20 Stantec reports Q3 EPS 62c, consensus 35c 05/06/21 Stantec - STN
Hot Stocks	Boeing reports 196 gross commercial airplane orders in March » 11:09 04/13/21 04/13 11:09 04/13/21 11:09 BA Boeing $248.68 / -0.98 (-0.39%) Boeing reported airplane… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA Boeing $248.68 / -0.98 (-0.39%) 11:04 Today Boeing announces 77 commercial airplane deliveries in Q1 04/09/21 Boeing recommends 16 customers address potential issue for some 737 MAX jets 04/08/21 Air Transport Services delivers third Boeing 767 freighter to Raya Airways 04/08/21 Air Lease delivers one new Boeing 737-8 aircraft to Belavia-Belarusian Airlines BA Boeing $248.68 / -0.98 (-0.39%) 04/09/21 Baird Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets 03/29/21 Goldman Sachs Boeing resuming 787 deliveries removes overhang, says Goldman Sachs 03/19/21 Susquehanna Boeing price target raised to $300 from $250 at Susquehanna 03/15/21 Morgan Stanley Aerospace sector upgraded to Attractive from Cautious at Morgan Stanley BA Boeing $248.68 / -0.98 (-0.39%) 01/27/21 Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) BA Boeing $248.68 / -0.98 (-0.39%) 04/09/21 Boeing 737 MAX issue impacts about 90 jets, Reuters reports 04/09/21 Boeing 737 MAX issue impacts about 90 jets, Reuters reports 03/29/21 Boeing urges Delaware court to dismiss investors' 737 MAX lawsuit, Reuters says 03/26/21 Boeing confirms 787 Dreamliner deliveries have resumed, Bloomberg says BA Boeing $248.68 / -0.98 (-0.39%) 04/09/21 Fly Intel: Wall Street's top stories for Friday 04/09/21 Fly Intel: Wall Street's top stories at midday 03/29/21 Fly Intel: Wall Street's top stories for Monday 03/29/21 Fly Intel: Wall Street's top stories at midday 04/15/21 Aerospace & Defense 04/28/21 Boeing - BA 04/20/21 Boeing Co. BA Boeing $248.68 / -0.98 (-0.39%) 03/29/21 Early notable gainers among liquid option names on March 29th 03/29/21 Unusually active option classes on open March 29th 03/17/21 Call buyers board Boeing as shares gain altitude following 2day slide 03/17/21 Early notable gainers among liquid option names on March 17th
Hot Stocks	Izea reports QTD managed services bookings exceeding bookings for year-ago » 11:09 04/13/21 04/13 11:09 04/13/21 11:09 IZEA Izea $5.03 / -0.275 (-5.18%) IZEA Worldwide announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Options IZEA Izea $5.03 / -0.275 (-5.18%) 04/12/21 Izea teases CEO live stream event on April 13 04/05/21 Izea reports Managed Services bookings up 130% year-over-year in Q1 03/18/21 IZEA appoints Peter Biere as CFO 03/08/21 Izea awarded influencer marketing contract expansion from Fortune 10 customer IZEA Izea $5.03 / -0.275 (-5.18%) 04/06/21 Ladenburg Izea upgraded to Neutral at Ladenburg as bookings accelerate 04/06/21 Ladenburg Izea upgraded to Neutral from Sell at Ladenburg 01/26/21 Fly Intel: Top five analyst downgrades 01/26/21 Ladenburg Ladenburg downgrades Izea to Sell on 'excessive' valuation IZEA Izea $5.03 / -0.275 (-5.18%) 01/26/21 Fly Intel: Pre-market Movers IZEA Izea $5.03 / -0.275 (-5.18%) 02/03/21 new option listings on February 3rd

Events

Earnings calls, analyst events, roadshows and more

HA
Today at 12:00

Hawaiian Airlines Executives Deliver Speech Government Event

Virtual Event
Today at 12:00

Fed Reserve Bank President Speaks on Economic Conditions Government Event

Virtual Event
Today at 12:00

Fed Reserve Bank President Delivers Opening Remarks Government Event

Virtual Event
Today at 12:00

Washington Research Policy Industry Meetings
Today at 12:00

Biotech/Pharma Industry Meetings
Today at 13:00

30-Year Bond Auction Government Event
AKRO
Today at 13:00

Akero Therapeutics - AKRO Conference Calls
Today at 13:15

Fed Reserve Bank President Moderates Virtual Panel Government Event

Virtual Event
BKSC
Today at 14:00

Bank of South Carolina Corp Firm Sponsored Meetings

256 Meeting St, Charleston, SC
Today at 14:00

Food/Agribusiness Industry Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	CHWY X CHWY Chewy Block Trade Managers: Morgan Stanley Priced at: $82.50 6.1M Shares EPRT X EPRT Essential Properties Realty Trust Spot Secondary Managers: Citi, BofA & Barclays Priced at: $23.50 7.15M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial GFL X GFL GFL Environmental Spot Secondary Managers: BMO Capital, RBC Capital & Scotiabank Priced at: $33.95 17.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	ALKT X ALKT Alkami IPO Managers: Goldman Sachs, JPMorgan & Barclays, Citi, William Blair, JMP Securities, KeyBanc, Needham $26.00-28.00 6M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	COIN X COIN Coinbase Direct Listing Managers: Direct Listing $ 114.851M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AGL X AGL Agilon Health IPO Managers: JPMorgan, Goldman Sachs & BofA, Deutsche Bank, Wells Fargo, William Blair, Truist, Nomura $20.00-23.00 46.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial APP X APP AppLovin IPO Managers: Morgan Stanley, JPMorgan, KKR, BofA & Citi, Credit Suisse, UBS, Oppenheimer, Stifel, Truist, William Blair, Truist, Luma, Guzman & Company, LionTree Advisors, The Raine Group, Blaylock Van, R. Seelaus $75.00-85.00 25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRT X KRT Karat Packaging IPO Managers: Stifel, William Blair & Truist, National Securities, DA Davidson $18.00-20.00 3.95M Shares TSP X TSP TuSimple IPO Managers: Morgan Stanley, Citi & JPMorgan, BofA, Cowen, Credit Suisse, Nomura, RBC Capital, Baird, Needham, Oppenheimer, Piper Sandler, Valuable Capital $35.00-39.00 33.784M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	AKYA X AKYA Akoya Biosciences IPO Managers: JPMorgan, Morgan Stanley, Piper Sandler & Canaccord $18.00-20.00 6.58M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BMEA X BMEA Biomea Fusion IPO Managers: JPMorgan, Jefferies & Piper Sandler $15.00-17.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RXRX X RXRX Recursion Pharmaceuticals IPO Managers: Goldman Sachs & JPMorgan, BofA, SVB Leerink, Allen & Co., KeyBanc $16.00-18.00 18M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BALY X BALY Bally's Secondary Managers: Deutsche Bank, Goldman Sachs & Barclays $60.80 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

Voyager Therapeutics announces anticipated upcoming milestones

TODAY'S FREE FLY STORIES

Get Full Fly Access